Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. (Q40831512)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Felicitas Hitz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Thomas Pabst

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Natalie Fischer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Anne Cairoli

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Panagiotis Samaras

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Clemens B Caspar

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Nicolas Mach

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Adrian Schmidt

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Christian Rothermundt

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Milica Enoiu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Katrin Eckhardt

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Simona Berardi Vilei

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Stephanie Rondeau

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Ulrich Mey

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

0 references

publication date

28 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

174

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

255-263

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sample size tables for exact single-stage phase II designs

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Lifetime risks of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Bendamustine: rebirth of an old drug

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Bendamustine's emerging role in the management of lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Therapeutic strategies in elderly and very elderly patients

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14049

21 January 2018

Identifiers

10.1111/BJH.14049

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27018242%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40831512&oldid=1815783961"